12:00 AM
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

Critical Pharmaceuticals, University of Nottingham deal

The university and Critical Pharmaceuticals partnered to develop an intranasal formulation of teriparatide to treat osteoporosis. The university's Technology Strategy Board and the Engineering and Physical Sciences Research Council...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >